These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Tracking health care costs: continued stability but at high rates in 2005. Ginsburg PB; Strunk BC; Banker MI; Cookson JP Health Aff (Millwood); 2006; 25(6):w486-95. PubMed ID: 17018565 [TBL] [Abstract][Full Text] [Related]
43. National health spending in 2004: recent slowdown led by prescription drug spending. Smith C; Cowan C; Heffler S; Catlin A Health Aff (Millwood); 2006; 25(1):186-96. PubMed ID: 16403753 [TBL] [Abstract][Full Text] [Related]
44. National health expenditures, 1998. Cowan CA; Lazenby HC; Martin AB; McDonnell PA; Sensenig AL; Stiller JM; Whittle LS; Kotova KA; Zezza MA; Donham CS; Long AM; Stewart MW Health Care Financ Rev; 1999; 21(2):165-210. PubMed ID: 11481774 [TBL] [Abstract][Full Text] [Related]
45. The case for a value-based formulary: striving for total lowest net cost. Weart W; Bauman GR Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330 [TBL] [Abstract][Full Text] [Related]
48. Weighing the evidence: trends in managed care formulary decision making. de Lissovoy G J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425 [TBL] [Abstract][Full Text] [Related]
49. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary? Cross M Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288 [No Abstract] [Full Text] [Related]
50. Spending on medicines in Israel in an international context. Sax P Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459 [TBL] [Abstract][Full Text] [Related]
51. Managed care and sexual dysfunction. Based on a presentation by William Parham, MD. Am J Manag Care; 1999 Jan; 5(1 Suppl):S23-7; discussion S28-30. PubMed ID: 10345973 [TBL] [Abstract][Full Text] [Related]
52. The effect of drug reimportation on managed care pharmacy. Penna P Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216 [No Abstract] [Full Text] [Related]
53. Programs take the edge off pharmacy cost increases. Capitation Manag Rep; 2002 Apr; 9(4):53-6, 49. PubMed ID: 12004735 [TBL] [Abstract][Full Text] [Related]
54. National trends in prescription drug expenditures and projections for 2016. Schumock GT; Li EC; Suda KJ; Wiest MD; Stubbings J; Matusiak LM; Hunkler RJ; Vermeulen LC Am J Health Syst Pharm; 2016 Jul; 73(14):1058-75. PubMed ID: 27170624 [TBL] [Abstract][Full Text] [Related]
56. Who lost cost containment? A roster for recrimination. Hurley R; Rawlings RB Manag Care Q; 2001; 9(4):23-32. PubMed ID: 11813454 [TBL] [Abstract][Full Text] [Related]
57. Focus on drugs. Vail S Can Nurse; 1996 Jan; 92(1):60, 59. PubMed ID: 8920559 [TBL] [Abstract][Full Text] [Related]
58. Will pharmacy costs overwhelm medical networks? Med Netw Strategy Rep; 1998 Aug; 7(8):1, 6-9. PubMed ID: 10182869 [TBL] [Abstract][Full Text] [Related]
59. Pharmaceutical formularies: the right formula for cost and utilization? Austin B Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009 [No Abstract] [Full Text] [Related]
60. National health spending in 2006: a year of change for prescription drugs. Catlin A; Cowan C; Hartman M; Heffler S; Health Aff (Millwood); 2008; 27(1):14-29. PubMed ID: 18180476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]